PubMed Health⌕ Search

PubMed · 9013085

Helicobacter pylori and proteolytic activity.

Abstract

Protease activity of 10 different H. pylori strains, purified marker proteases and protease-positive reference bacteria (Klebsiella ozaenae, Serratia marcescens) were tested against bovine haemoglobin, porcine mucin, bovine serum albumin, gelatin and casein as substrates. After incubation in development buffer and subsequent staining with Coomassie blue, protease activity bands were demonstrated as transparent spots after polyacrylamide gel electrophoresis (PAGE) on gels with incorporated substrate. Presence of protease activity was investigated in a wide pH range (pH 2.0-9.0). Although marker proteases (0.15-0.2 microgram per slot) as well as protease-positive bacteria (2-30 micrograms per slot) clearly showed proteolytic activity in gels containing 0.1-0.2% protein mL-1, no proteolytic activity was demonstrated in any of the H. pylori strains tested. This finding indicates that H. pylori does not possess significant protease activity, as this would have been detected by this sensitive method.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Nilius, M Pugliese, P Malfertheiner. 1996. Helicobacter pylori and proteolytic activity.. https://doi.org/10.1046/j.1365-2362.1996.470598.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗